Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.05
HEWA's Cash to Debt is ranked lower than
51% of the 502 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.65 vs. HEWA: 0.05 )
HEWA' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.05

Equity to Asset -4.37
HEWA's Equity to Asset is ranked lower than
56% of the 505 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. HEWA: -4.37 )
HEWA' s 10-Year Equity to Asset Range
Min: -4.37   Max: 0.84
Current: -4.37

-4.37
0.84
F-Score: 5
Z-Score: -43.57
M-Score: 62.31
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -23.79
HEWA's Operating margin (%) is ranked lower than
55% of the 500 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.67 vs. HEWA: -23.79 )
HEWA' s 10-Year Operating margin (%) Range
Min: -145.68   Max: 8.45
Current: -23.79

-145.68
8.45
Net-margin (%) -53.65
HEWA's Net-margin (%) is ranked lower than
55% of the 500 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.14 vs. HEWA: -53.65 )
HEWA' s 10-Year Net-margin (%) Range
Min: -142.82   Max: 6.86
Current: -53.65

-142.82
6.86
ROA (%) -386.62
HEWA's ROA (%) is ranked lower than
56% of the 500 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.28 vs. HEWA: -386.62 )
HEWA' s 10-Year ROA (%) Range
Min: -386.62   Max: 11.29
Current: -386.62

-386.62
11.29
ROC (Joel Greenblatt) (%) -389.44
HEWA's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 499 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 19.49 vs. HEWA: -389.44 )
HEWA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1326.98   Max: 24
Current: -389.44

-1326.98
24
Revenue Growth (%) -8.30
HEWA's Revenue Growth (%) is ranked higher than
50% of the 442 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.90 vs. HEWA: -8.30 )
HEWA' s 10-Year Revenue Growth (%) Range
Min: -62.1   Max: 84.2
Current: -8.3

-62.1
84.2
EBITDA Growth (%) -7.70
HEWA's EBITDA Growth (%) is ranked higher than
58% of the 400 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.00 vs. HEWA: -7.70 )
HEWA' s 10-Year EBITDA Growth (%) Range
Min: -79.5   Max: 98.8
Current: -7.7

-79.5
98.8
EPS Growth (%) -16.90
HEWA's EPS Growth (%) is ranked higher than
59% of the 378 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.30 vs. HEWA: -16.90 )
HEWA' s 10-Year EPS Growth (%) Range
Min: -77.9   Max: 86.1
Current: -16.9

-77.9
86.1
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.51
HEWA's P/S is ranked higher than
63% of the 519 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.48 vs. HEWA: 0.51 )
HEWA' s 10-Year P/S Range
Min: 0.2   Max: 29.23
Current: 0.51

0.2
29.23
EV-to-EBIT -3.98
HEWA's EV-to-EBIT is ranked higher than
50% of the 519 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.30 vs. HEWA: -3.98 )
HEWA' s 10-Year EV-to-EBIT Range
Min: 11.5   Max: 116.8
Current: -3.98

11.5
116.8
Current Ratio 0.06
HEWA's Current Ratio is ranked lower than
59% of the 343 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.23 vs. HEWA: 0.06 )
HEWA' s 10-Year Current Ratio Range
Min: 0.06   Max: 5.83
Current: 0.06

0.06
5.83
Quick Ratio 0.03
HEWA's Quick Ratio is ranked lower than
59% of the 343 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.68 vs. HEWA: 0.03 )
HEWA' s 10-Year Quick Ratio Range
Min: 0.02   Max: 5.83
Current: 0.03

0.02
5.83

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.41
HEWA's Price/Median PS Value is ranked higher than
97% of the 519 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.12 vs. HEWA: 0.41 )
HEWA' s 10-Year Price/Median PS Value Range
Min: 0.25   Max: 14.18
Current: 0.41

0.25
14.18
Forward Rate of Return (Yacktman) -182.69
HEWA's Forward Rate of Return (Yacktman) is ranked higher than
53% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.32 vs. HEWA: -182.69 )
HEWA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -182.69

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
HealthWarehouse.com, Inc. was formerly known as Ion Networks, Inc. On May 14, 2009, it completed a share exchange transaction pursuant to the terms of a Securities Exchange Agreement, dated as of May 14, 2009. Under the Securities Exchange Agreement, it acquired all the outstanding capital stock of HealthWarehouse.com, Inc., a Delaware corporation (HW). Subsequently the Company changed its corporate name to HealthWarehouse.com, Inc. It is a U.S. licensed pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter (OTC) medical products. It sells a range of prescription drugs (it is licensed as a mail-order pharmacy for sales to 36 states and the District of Columbia); diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids; home medical supplies including incontinence supplies, first aid kits and mobility aids; and diet and nutritional products including supplements, weight loss aids, and vitamins and minerals. The Company's objective is to be viewed by individual healthcare product consumers as a low-cost, reliable and hassle-free provider of prescription drugs and OTC medical products. The Company's website facilitates convenience and future shopping by allowing for on-the-fly product comparisons. It offers an industry-leading 90-day return policy with no restocking fees, 100% free standard shipping, and it only sells products which are U.S. Food and Drug Administration (FDA) approved and legal in the United States. It breaks down its business model into three components: commerce, content and community. It operates a full-service mail-order pharmacy within its warehouse in Cincinnati, Ohio. The pharmacy includes a machine which counts and packages prescriptions that could fill up to 1,200 prescriptions per day. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's marketing strategy aims to build brand recognition, increase customer traffic to its online store, add new customers, build strong customer loyalty, maximize repeat purchases and develop incremental revenue opportunities. It is centered on Internet-based advertising. It applied for a trademark on the name 'HealthWarehouse.com' that was approved by the U.S. Patent and Trade Office effective April 4, 2009. The market for prescription and OTC health products is intensely competitive and highly fragmented. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK